在指数收获亮眼涨幅的情况下，相关指增产品同样迎开门红。私募排排网数据显示，截至2月13日，172只中证500指增产品，今年来的收益均值 为9.80%，在众多指增策略产品中表现亮眼；近3年收益均值为78.96%，大幅跑赢中证500指数。 本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 2026年以来的A股市场，正上演着一场深刻的风格转换，截至2月27日，中证500指数以近16%的涨幅，悄然领跑沪深300、中证1000等主流宽基 指数，创下近十年新高。 0 1 为什么中证500指数能逆势领先？ 中证500指数的行业分布使其兼具科技成长和周期复苏的双重逻辑，这使得其今年涵盖了多个题材轮动的赛道，充分享受了市场红利。代表的是 A股市场中排名第301至800名的中盘股，是连接大盘蓝筹（沪深300）与小盘成长（中证1000）的"腰部力量"。 α收益（阿尔法收益）：通过基金经理的主动管理获得的超额回报，也是 "增强"二字的含义所在 ， 这部分收益考验的是基金管理人的投研能 力。 今年来，科技板块如商业航天、半导体、人形机器人等新兴产业概念持续火热；周期板块中，涨价潮带来有色金属、光伏等活跃，这些板块恰恰 是 ...

指增超额回撤控制：波动率分域视角 ——主动量化研究系列 核心观点 本报告中，我们继续就如何管理指增超额回撤进行研究。核心结论是：根据个股残差 波动率进行分域管理，放宽低波个股偏离约束，收紧高波偏离约束，对超配/低频限制 进行独立管理，可得到更优收益风险组合。 ❑ 风险来源于阿尔法，适当的风格敞口是必要的 阿尔法因子，无论基本面还是量价，多数与动量、波动率、流动性、市值存在较 强相关性。例如成长，其与动量、波动率、贝塔、流动性存在显著正相关关系； 超预期，与动量也存在较强的正相关性。 ❑ 个股权重偏离是更有效的抓手 收益维度，严约束风格敞口会较大程度上降低长期超额表现；风险维度，风险因 子解释度导致中性化敞口仍不足以有效平滑波动。个股权重偏离作为风险/收益 的本质来源，对其进行针对性管理，可操作性和效果更好。 ❑ 优化：残差波动率分域管理 超配/低配标的池内因子有效性反转，是回撤的直接原因。在无法预判风险的前 提下，降低发生时的影响更有价值。以残差波动率为划分指标，对高、中、低波 股票池个股权重偏离进行分域管理。从结果看，可在较小影响长期超额的前提 下，降低组合波动和回撤大小。 ❑ 风险提示 收益指标等指标均限 ...

Core Insights - 2025 is a landmark year for quantitative investment, marked by the emergence of DeepSeek, which injects disruptive AI momentum into the field [3] - The A-share market has shown a significant upward trend, with small and mid-cap stocks outperforming, as evidenced by the over 36% and 80% increases in the CSI 2000 and micro-cap indices respectively [3] - The average return for quantitative private equity products in 2025 reached 30.28%, with a geometric excess return of 10.83% [3] Quantitative Strategy Performance - The top-performing quantitative long strategy products, totaling 806, achieved returns of 44.74% and geometric excess returns of 16.46% in 2025, leading among private equity secondary strategies [4] - Other strategies such as quantitative CTA and stock market neutral also performed well, with average returns of 20.21% and 9.58% respectively [4][5] Quantitative Stock Selection - The average return for quantitative stock selection products was 42.28% in 2025, with an average excess return of 17.70% [6] - The top three products in this category were from Hainan Gaia Qingke Private Equity, Water Mill Asset, and Hanrong Investment [6] Notable Products and Managers - Hainan Gaia Qingke's product "Gaia Qingke Cattail Progress A" achieved outstanding performance, with returns exceeding ***% [7] - Hanrong Investment's "Hanrong Ansheng Progress No. 1 B" also performed well, with returns exceeding ***% [8] - Longqi Technology's "Longqi Technology Innovation Selected No. 1 C" led the quantitative stock selection products with returns exceeding ***% [9] CSI 500 Index Enhancement - The average return for CSI 500 index enhancement products was 46.32% in 2025, with an average excess return of 12.22% [10] - The top three products in this category were from Guobiao Asset, Zhaoxin Private Equity Fund, and Zhaoyue Private Equity [10] CSI 1000 Index Enhancement - The average return for CSI 1000 index enhancement products was 49.68% in 2025, with an average excess return of 17.41% [14] - The top three products were from Jintong Investment, Luxiu Investment, and Mengxi Investment [14] Other Index Enhancements - The average return for other index enhancement products was 46.76% in 2025, with an average excess return of 19.95% [23] - The top three products in this category were from Jing Shang Jia Wan, Zhongmin Huijin, and Yang Shi Asset [24]

Core Viewpoint - In 2025, index-enhanced products are expected to experience significant excess returns, driven by factors such as a daily trading volume of 1.7 trillion yuan in the Shanghai and Shenzhen markets, advancements in AI technology enhancing alpha extraction capabilities, and a favorable style for small and mid-cap indices [2] Summary by Category Performance of Index-Enhanced Products - A total of 471 index-enhanced products are projected for 2025, with an average return of 46.47% and an average excess return of 15.56% [2][4] - Among these, 177 products from private equity firms with over 10 billion yuan in assets have the highest average return of 49.05% and an average excess return of 17.45% [4] Performance by Strategy - The top-performing strategies in 2025 include: - Quantitative stock selection with an average excess return of 28.29% and an average return of 55.06% [6] - CSI 1000 index enhancement with an average excess return of 21.24% and an average return of 54.56% [5][6] - CSI 500 index enhancement with an average excess return of 15.80% and an average return of 50.99% [13][6] Top Products in Each Category - For the CSI 1000 index enhancement, the top products are managed by: - Mengxi Investment with an outstanding performance [8][12] - Mingyuan Investment and Square Investment also rank highly [8] - In the CSI 500 index enhancement category, the leading products are managed by: - Wanyan Asset and Mingyuan Fund [13][16] - Other index-enhanced products are led by: - Yanfu Investment with significant returns [19][20] Notable Managers and Firms - Mengxi Investment's Li Xiang emphasizes the transformative impact of AI on investment strategies, focusing on data processing and model optimization [12] - Mingyuan Investment, known for its application of AI in finance, maintains a strong position in the quantitative investment sector [12] - Wanyan Asset's Jin Teng has extensive experience in quantitative research and investment management [16][18] - Yanfu Investment's Gao Kang, a former researcher at Two Sigma, leads the top-performing small-cap index enhancement product [24] Market Trends and Insights - The small-cap stock style is expected to dominate in 2025, contributing to the strong performance of the CSI 1000 index enhancement products [5] - The overall market environment, characterized by high liquidity and technological advancements, is conducive to achieving high excess returns in index-enhanced products [2]

Core Insights - Deepseek has emerged as a significant player in the global AI landscape, revitalizing the quantitative investment sector, particularly in a market environment favoring small and mid-cap stocks [2] - In November, despite an overall adjustment in the A-share market, many quantitative products from billion-yuan private equity firms achieved historical highs, with quantitative products accounting for over 80% of these successes [2] - The average return for 1,833 quantitative products this year is 26.98%, with an excess (geometric) return of 11.41% [2][3] Quantitative Investment Performance - The average return for quantitative long strategies is 40.34%, with an excess return of 17.25%, making it the top performer among secondary strategies [3] - The performance of various quantitative strategies is summarized as follows: - Quantitative CTA: 16.32% average return, 13.76% excess return - Stock market neutral: 9.37% average return, -4.93% excess return - Composite strategies: 23.85% average return, 7.61% excess return - Options strategies: 11.04% average return, 8.60% excess return - Convertible bond trading strategies: 20.42% average return, 3.65% excess return - Arbitrage strategies: 11.63% average return, -2.96% excess return - Macro strategies: 21.72% average return, 5.69% excess return - Stock long-short: 15.05% average return, 0.01% excess return - FOF: 13.50% average return, -1.33% excess return - Bond composite strategies: 13.88% average return, 13.15% excess return - Pure bond strategies: 6.47% average return, 5.79% excess return - Other derivative strategies: 37.74% average return, 34.72% excess return - Bond enhancement: 11.47% average return, 10.76% excess return [3] Top Performing Quantitative Products - The "quantitative stock selection" products have an average return of 39.40% and an average excess return of 19.14% [4] - The top three products in the "quantitative stock selection" category are from: - Zhuhai Zhengfeng Private Equity - Shui Du Quan Asset - Jiu Ming Investment [5] - The "CSI 500 index enhancement" products have an average return of 40.17% and an average excess return of 14.14% [8] - The top three products in the "CSI 500 index enhancement" category are from: - Zhaoxin Private Equity Fund - Guobiao Asset - Zhaoyue Private Equity [9] - The "CSI 1000 index enhancement" products have an average return of 44.68% and an average excess return of 17.53% [13] - The top three products in the "CSI 1000 index enhancement" category are from: - Jintong Investment - Luxiu Investment - Mengxi Investment [13] Other Notable Strategies - The "CSI 300 index enhancement" products have an average return of 24.47% and an average excess return of 8.20% [17] - The top three products in the "CSI 300 index enhancement" category are from: - Hainan Pengpai Private Equity - Ningbo Huansheng Quantitative - Mingyun Investment [17] - The "other index enhancement" products have an average return of 42.58% and an average excess return of 20.13% [20] - The top three products in the "other index enhancement" category are from: - Yangshi Asset - Luxiu Investment - Shengguanda [21]

Group 1 - DeepSeek has gained global attention due to its technological breakthroughs and its unique stance of not seeking external financing, which highlights the management's financial strength [1] - The company is backed by a well-established cash flow generator, which has recently come to light, altering the perception of DeepSeek's operational model [1] Group 2 - Huanfang Quantitative, founded by Liang Wenfeng, has seen a significant performance resurgence, with its stock long/short strategy yielding approximately 50% returns in the first eleven months of 2025, outperforming the CSI 1000 and CSI 500 indices by about 30 percentage points [2][5] - This resurgence is attributed to the revival of classic factors in the market, particularly in the crowded areas of the CSI 1000 and CSI 500 indices, indicating a return to effective strategies after a period of underperformance [5][6] Group 3 - Huanfang's asset management scale reportedly shrank to around 20 billion yuan, leading to decreased market attention as focus shifted to larger firms with over 50 billion yuan in assets [7][8] - Despite the reduction in external management scale, Huanfang's internal self-managed portfolio has remained a critical support for its business, although specific performance figures for this internal portfolio are not publicly disclosed [10][15] Group 4 - The performance of Huanfang's external asset management products, which have maintained around 50% returns, suggests that the internal self-managed portfolio likely mirrors this success, if not exceeding it [16] - The resurgence of Huanfang's performance may indicate potential shifts in the private equity landscape and could signal an increased investment in large model initiatives within China [17]

Core Viewpoint - The A-share market has shown a continuous upward trend since the "9.24 market" last year, with significant gains in major indices, leading to a favorable investment environment for long-only private equity funds, particularly in quantitative strategies which have outperformed traditional subjective strategies [2][3]. Group 1: Market Performance - As of November 2025, the Shanghai Composite Index has increased by 16.90%, while the Shenzhen Composite Index and the ChiNext Index have risen by approximately 22.36% and 37.26% respectively, indicating a strong overall market performance [2]. - Quantitative long-only products have shown impressive results, with 785 products achieving an average return of 38.48%, surpassing the 35.16% average return of subjective long strategies [2][3]. Group 2: Private Equity Strategy Performance - Among various private equity strategies, quantitative long strategies lead with an average return of 38.48%, followed by subjective long strategies at 35.16%, and other derivative strategies at 31.15% [3]. - The total number of private equity products with performance data is 4,991, with a combined scale of approximately 3,994.81 billion [3]. Group 3: Quantitative Stock Selection - There are 27 private equity firms with at least three quantitative stock selection products, totaling 98 products and a combined scale of about 119.15 billion [5]. - The top three private equity firms in terms of excess return from quantitative stock selection are Lingjun Investment, Minghong Investment, and Longyin Tiger, with their average excess returns being noteworthy [5][6]. Group 4: Mid-Cap Index Strategy - For the CSI 500 index enhancement strategy, 12 private equity firms have a total of 62 products, with a combined scale of approximately 66.84 billion [8]. - The leading firms in this strategy are Ningbo Huansheng Quantitative, Qianyan Private Equity, and Century Frontier, showcasing strong performance in excess returns [8][9].

Core Viewpoint - Quantitative products are systematic investment methods based on mathematical models, algorithms, and computer technology, with the ability to generate excess returns being a key indicator of their effectiveness [2] Group 1: Quantitative Excess Rate - The quantitative excess rate is defined as the frequency or probability of a quantitative strategy outperforming a benchmark index over a certain period, calculated as the number of times it beats the benchmark divided by the total observation periods [2] - A higher quantitative excess rate indicates that the strategy can maintain positive excess returns most of the time, reducing the risk of significant drawdowns or prolonged underperformance [2] Group 2: Performance of Billion-Level Quantitative Private Equity - In 2023, 388 quantitative products from billion-level private equity firms achieved an average return of 34.26%, with an excess return of 10.87% and an average excess rate of 61.33%, significantly leading among various scales of private equity [3] - The average performance metrics for different scales of private equity are as follows: - 100 billion and above: 34.26% return, 10.87% excess, 61.33% excess rate - 50-100 billion: 25.20% return, 8.14% excess, 56.48% excess rate - 20-50 billion: 27.19% return, 10.77% excess, 55.91% excess rate - 10-20 billion: 26.56% return, 8.95% excess, 54.63% excess rate - 5-10 billion: 26.05% return, 8.99% excess, 53.59% excess rate - 0-5 billion: 24.37% return, 10.11% excess, 52.63% excess rate - Total: 27.64% return, 9.90% excess, 55.86% excess rate [3] Group 3: Top Performers in Quantitative Strategies - The top three products with the highest excess rates in the CSI 300 index enhancement category are from Minghuo Investment, Ningbo Huanfang Quantitative, and Kuande Private Equity, with the average excess rate for billion-level private equity in this category being 64.59% [4] - In the CSI 500 index enhancement category, the top three products are from Wanyan Asset, Pansong Asset, and Tianyan Capital, with an average excess rate of 67.28% for billion-level private equity [10] - In the CSI 1000 index enhancement category, the top three products are from Microbo Yi, Mengxi Investment, and Yanfeng Investment, with an average excess rate of 76.17% for billion-level private equity [10] Group 4: Quantitative Stock Selection - The average return for quantitative stock selection products in 2023 is 40.45%, with an excess return of 16.55% and an average excess rate of 58.26%, while billion-level private equity in this category has an average excess rate of 65.97% [13] - The top three products in this category are from Jiukun Investment, Tianyan Capital, and Longqi Technology [13]

Group 1 - The core viewpoint of the article is that index-enhanced ETFs are an innovative product that combines the advantages of index enhancement strategies and ETFs, leading to significant growth in the market [1][68]. - As of October 31, 2025, there are 51 index-enhanced ETFs in the market with a total scale of 95.73 billion, of which 7 ETFs track the CSI 500 index, amounting to 25.92 billion [1][68]. Group 2 - The CSI 500 index consists of 500 stocks with higher market capitalization after excluding the top 300 stocks from the CSI 300 index, providing a diversified industry distribution and currently trading below historical valuation averages [2][70]. - The scale of CSI 500 index-enhanced funds reached 493.46 billion by Q3 2025, accounting for over one-fifth of all enhanced funds, with stable excess returns [1][70]. Group 3 - The Bosera CSI 500 Enhanced Strategy ETF (159678.SZ) was launched on February 27, 2023, and aims to achieve returns exceeding the benchmark index through quantitative enhancement strategies [1][71]. - Since its inception, the fund has achieved an annualized excess return of 7.76% with a tracking error of only 3.84%, indicating strong risk-adjusted performance [1][71].

Core Insights - The A-share market has entered a volatile rotation phase since October, with significant recovery in the returns of quantitative products [2] - Among the 825 quantitative long products with performance data, the average return for the year is 41.02%, with an excess return of 14.36% [3] Summary by Category Performance of Strategies - Quantitative long products have the highest average return in October among all stock strategy products, reaching 0.93% with an average excess return of 1.5% [2] - The performance of various strategies is as follows: - Quantitative long: 825 products, average return 41.02%, monthly return 0.93% [3] - Subjective long: 2156 products, average return 36.11%, monthly return -1.35% [3] - Macro strategy: 201 products, average return 27.17%, monthly return 0.96% [3] - Composite strategy: 409 products, average return 25.66%, monthly return 1.11% [3] - Other derivative strategies: 15 products, average return 25.63%, monthly return 4.45% [3] Top Performing Products - In the quantitative long category, the top products by excess return include: - CSI 1000 index enhancement: 158 products, average return 45.51%, excess return 15.48% [4] - Quantitative stock selection: 329 products, average return 39.25%, excess return 15.56% [4] - CSI 500 index enhancement: 201 products, average return 42.07%, excess return 10.96% [4] - CSI 300 index enhancement: 38 products, average return 25.62%, excess return 6.52% [4] - Other index enhancements: average return 43.55%, excess return 18.52% [4] Notable Fund Managers - The top products in the CSI 1000 index enhancement category are managed by notable fund managers from large private equity firms, with the highest returns coming from companies like Jintong Investment and Luxiu Investment [5][9] - In the quantitative stock selection category, the top products are managed by firms such as Longqi Technology and Jiuming Investment [10][12] - The CSI 500 index enhancement products are led by managers from Guobiao Asset and Zhaoxin Private Fund [13][16] - The CSI 300 index enhancement products are managed by firms like Hainan Pengpai Private Fund and Ningbo Huansquare Quantitative [17][20] - Other index enhancement products are managed by firms such as Liangchuang Investment and Yangshi Asset [21][23]